ArticleJACC. Advances2026
Feasibility and Safety of Same-Day Discharge Following Elective Mitral Transcatheter Edge-to-Edge Repair.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundData on the feasibility and safety of same-day discharge (SDD) following mitral transcatheter edge-to-edge repair (M-TEER) remain limited.
objectivesThe objective of the study was to evaluate the contemporary trends and outcomes of SDD following M-TEER.
methodsWe reviewed the Nationwide Readmissions Database (2016-2022) to compare SDD following elective M-TEER with next-day discharge (NDD). The primary outcome was unplanned all-cause readmissions within 90 days. Secondary outcomes included 90-day heart failure (HF) readmissions and index hospitalization costs. Readmissions were compared using a Cox proportional hazards regression model.
resultsA total of 39,804 weighted hospitalizations for M-TEER were included, of which 1.2% involved SDD, 69.0% NDD, and 29.8% second- or third-day discharge (ScD/TDD). From 2016 to 2022, the proportion of SDD and NDD increased from 0.4% to 2.4% and 47.9% to 76.7%, respectively, whereas ScD/TDD decreased from 51.7% to 20.9% (all p
conclusionsSDD following M-TEER is uncommon but associated with a similar risk of 90-day readmission and lower index hospitalization costs compared to NDD. Further research is warranted to identify optimal patient selection criteria for SDD after M-TEER.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.